Falko Nagel

735 total citations
18 papers, 575 citations indexed

About

Falko Nagel is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Falko Nagel has authored 18 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Falko Nagel's work include Receptor Mechanisms and Signaling (11 papers), Neuroendocrine Tumor Research Advances (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Falko Nagel is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuroendocrine Tumor Research Advances (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Falko Nagel collaborates with scholars based in Germany, United Kingdom and Switzerland. Falko Nagel's co-authors include Stefan Schulz, Amelie Lupp, Christian Doll, Herbert Schmid, Diana Lehmann, Ralf Stumm, Andrea Kliewer, Dagmar Schütz, Stefan Jacobs and Thomas Fischer and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Falko Nagel

18 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Falko Nagel Germany 13 261 225 186 174 104 18 575
Hicham Lahlou France 13 204 0.8× 335 1.5× 263 1.4× 101 0.6× 154 1.5× 14 843
Francine Hébert United States 15 247 0.9× 185 0.8× 251 1.3× 240 1.4× 67 0.6× 18 632
Hiromichi Nakabayashi Japan 15 99 0.4× 206 0.9× 123 0.7× 78 0.4× 28 0.3× 24 547
Katharina H. Ruebel United States 16 186 0.7× 322 1.4× 199 1.1× 233 1.3× 29 0.3× 22 725
DeLellis Ra United States 14 157 0.6× 150 0.7× 123 0.7× 176 1.0× 100 1.0× 25 569
Carole Auger France 15 113 0.4× 205 0.9× 45 0.2× 369 2.1× 113 1.1× 31 753
Shinji Kagimoto Japan 11 595 2.3× 407 1.8× 284 1.5× 303 1.7× 146 1.4× 14 995
Sven Radetzky Germany 8 96 0.4× 177 0.8× 100 0.5× 34 0.2× 39 0.4× 10 651
Allen M. Spiegel United States 12 72 0.3× 314 1.4× 146 0.8× 61 0.4× 50 0.5× 12 704
Kishore K. Murthy Canada 11 87 0.3× 235 1.0× 85 0.5× 55 0.3× 38 0.4× 17 506

Countries citing papers authored by Falko Nagel

Since Specialization
Citations

This map shows the geographic impact of Falko Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falko Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falko Nagel more than expected).

Fields of papers citing papers by Falko Nagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Falko Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falko Nagel. The network helps show where Falko Nagel may publish in the future.

Co-authorship network of co-authors of Falko Nagel

This figure shows the co-authorship network connecting the top 25 collaborators of Falko Nagel. A scholar is included among the top collaborators of Falko Nagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Falko Nagel. Falko Nagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schaffner, Anne E., Julia Drube, Falko Nagel, et al.. (2024). Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphorylation immunoassay. European Journal of Pharmacology. 973. 176587–176587. 1 indexed citations
2.
Fritzwanker, Sebastian, et al.. (2023). In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies. Communications Biology. 6(1). 419–419. 3 indexed citations
3.
Jenkins, Laura, Sara Marsango, Daniele Bolognini, et al.. (2023). Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner. eLife. 12. 6 indexed citations
4.
Marsango, Sara, Richard J. Ward, Laura Jenkins, et al.. (2022). Selective phosphorylation of threonine residues defines GPR84–arrestin interactions of biased ligands. Journal of Biological Chemistry. 298(5). 101932–101932. 13 indexed citations
5.
Kliewer, Andrea, et al.. (2016). Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking. Molecular Endocrinology. 30(6). 645–659. 15 indexed citations
7.
Kliewer, Andrea, et al.. (2014). Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor. Molecular and Cellular Endocrinology. 387(1-2). 44–51. 13 indexed citations
8.
Schütz, Dagmar, et al.. (2013). Hierarchical Organization of Multi-Site Phosphorylation at the CXCR4 C Terminus. PLoS ONE. 8(5). e64975–e64975. 55 indexed citations
9.
Lupp, Amelie, Falko Nagel, & Stefan Schulz. (2013). Reevaluation of sst1 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7. Regulatory Peptides. 183. 1–6. 25 indexed citations
10.
Schulz, Stefan, et al.. (2013). Fine‐tuning somatostatin receptor signalling by agonist‐selective phosphorylation and dephosphorylation: IUPHAR Review 5. British Journal of Pharmacology. 171(7). 1591–1599. 10 indexed citations
11.
Mann, Anika, et al.. (2013). Phosphorylation of Threonine 333 Regulates Trafficking of the Human sst5 Somatostatin Receptor. Molecular Endocrinology. 27(4). 671–682. 26 indexed citations
12.
Lupp, Amelie, Falko Nagel, Christian Doll, et al.. (2012). Reassessment of sst<sub>3</sub> Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-5. Neuroendocrinology. 96(4). 301–310. 42 indexed citations
14.
Nagel, Falko, et al.. (2011). Structural Determinants of Agonist-Selective Signaling at the sst2A Somatostatin Receptor. Molecular Endocrinology. 25(5). 859–866. 26 indexed citations
16.
Lehmann, Diana, et al.. (2008). Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro. The Journal of Clinical Endocrinology & Metabolism. 94(2). 654–661. 137 indexed citations
17.
Fischer, Thomas, Falko Nagel, Stefan Jacobs, Ralf Stumm, & Stefan Schulz. (2008). Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2. PLoS ONE. 3(12). e4069–e4069. 58 indexed citations
18.
Mikhaylova, Marina, Yogendra Sharma, Carsten Reißner, et al.. (2006). Neuronal Ca2+ signaling via caldendrin and calneurons. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763(11). 1229–1237. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026